We used phase contrast (PC) and T2-Relaxation-Under-Spin-Tagging (TRUST) to evaluate whole brain cerebral metabolic rate of oxygen (CMRO2) in MS patients and healthy controls. We compared CMRO2 with cognitive performance and diffusion kurtosis imaging. CMRO2 correlates negatively with cognitive function in MS patients, suggesting a marker of ongoing disease activity leading to cognitive decline.
This abstract and the presentation materials are available to members only; a login is required.